WO2010122473A3 - A medicinal antifungal and steroid cream incorporating a biopolymer and a process to make it - Google Patents
A medicinal antifungal and steroid cream incorporating a biopolymer and a process to make it Download PDFInfo
- Publication number
- WO2010122473A3 WO2010122473A3 PCT/IB2010/051689 IB2010051689W WO2010122473A3 WO 2010122473 A3 WO2010122473 A3 WO 2010122473A3 IB 2010051689 W IB2010051689 W IB 2010051689W WO 2010122473 A3 WO2010122473 A3 WO 2010122473A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- skin
- biopolymer
- treating fungal
- clotrimazole
- infections
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
- A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
- A61L26/0023—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
- A61L26/0061—Use of materials characterised by their function or physical properties
- A61L26/0066—Medicaments; Biocides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
- A61L2300/22—Lipids, fatty acids, e.g. prostaglandins, oils, fats, waxes
- A61L2300/222—Steroids, e.g. corticosteroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/45—Mixtures of two or more drugs, e.g. synergistic mixtures
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Materials Engineering (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
The present invention is directed to a composition for treating fungal skin infections & skin inflammation, along with skin rejuvenation containing a) a biopolymer in the form of Chitosan, b) a combination of active pharmaceutical ingredients (APIs), namely Clotrimazole & Mometasone Furoate, used in treating fungal skin infections & skin inflammations, c) a cream base containing primary and secondary emulsifiers, waxy materials, co-solvents, acids, preservatives, buffering agents, anti oxidants, chelating agents, and humectants, and d) water. The active ingredients, namely chitosan, a corticosteroid in the form of Mometasone Furoate, and an antifungal agent in the form of Clotrimazole, are incorporated in cream base for use in treating fungal skin infections and skin inflammation due to allergy & itching, & wounds on human skin involving contacting human skin with the above identified composition.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN1023/MUM/2009 | 2009-04-20 | ||
IN1023MU2009 | 2009-04-20 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2010122473A2 WO2010122473A2 (en) | 2010-10-28 |
WO2010122473A3 true WO2010122473A3 (en) | 2010-12-29 |
Family
ID=42945116
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/IB2010/051689 WO2010122473A2 (en) | 2009-04-20 | 2010-04-19 | A medicinal antifungal and steroid cream incorporating a biopolymer and a process to make it |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2010122473A2 (en) |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20080206161A1 (en) * | 2002-10-25 | 2008-08-28 | Dov Tamarkin | Quiescent foamable compositions, steroids, kits and uses thereof |
-
2010
- 2010-04-19 WO PCT/IB2010/051689 patent/WO2010122473A2/en active Application Filing
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20080206161A1 (en) * | 2002-10-25 | 2008-08-28 | Dov Tamarkin | Quiescent foamable compositions, steroids, kits and uses thereof |
Non-Patent Citations (5)
Title |
---|
ABDELMAGEED O H ET AL: "Spectrophotometric determination of clotrimazole in bulk drug and dosage forms", TALANTA, ELSEVIER, AMSTERDAM, NL LNKD- DOI:10.1016/0039-9140(93)80200-B, vol. 40, no. 8, 1 August 1993 (1993-08-01), pages 1289 - 1294, XP026552334, ISSN: 0039-9140, [retrieved on 19930801] * |
MARRAS F: "THERAPEUTIC USEFULNESS OF A CORTICOSTEROID ANTIBACTERIAL AND ANTIFUNGAL COMBINATION IN SKIN DISEASES OF VARIOUS ORIGINS", PHARMATHERAPEUTICA, CLAYTON-WRAY PUBLICATIONS, LONDON, GB, vol. 4, no. 2, 1 January 1985 (1985-01-01), pages 88 - 91, XP009133482, ISSN: 0308-051X * |
PAZZAGLIA A: "THERAPEUTIC EFFECTS AND TOLERANCE OF AN EXTEMPORE COMBINATION OF AN ANTIBACTERIAL ANTI-INFLAMMATORY AND ANTIMYCOTIC CREAM IN SKIN DISEASES OF VARIOUS ORIGINS", PHARMATHERAPEUTICA, CLAYTON-WRAY PUBLICATIONS, LONDON, GB, vol. 4, no. 2, 1 January 1985 (1985-01-01), pages 122 - 125, XP009133483, ISSN: 0308-051X * |
RAVI KUMAR M N V: "A review of chitin and chitosan applications", REACTIVE & FUNCTIONAL POLYMERS, ELSEVIER SCIENCE PUBLISHERS BV, NL LNKD- DOI:10.1016/S1381-5148(00)00038-9, vol. 46, no. 1, 1 November 2000 (2000-11-01), pages 1 - 27, XP004224437, ISSN: 1381-5148 * |
REGOS J ET AL: "ANTIMICROBIAL SPECTRUM OF TRICLOSAN, A BROAD-SPECTRUM ANTIMICROBIAL AGENT FOR TOPICAL APPLICATON II. COMPARISON WITH SOME OTHER ANTIMICROBIAL AGENTS", DERMATOLOGICA, S.KARGER, BASEL, CH, vol. 158, no. 1, 1 January 1979 (1979-01-01), pages 72 - 79, XP008034149, ISSN: 0011-9075 * |
Also Published As
Publication number | Publication date |
---|---|
WO2010122473A2 (en) | 2010-10-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2010109434A3 (en) | A medicinal antibacterial, antifungal and steroids cream comprising chitosan and a process to make it | |
WO2010119364A3 (en) | A medicinal cream made using neomycin sulphate, betamethasone valerate, and chitosan, and a process to make the same | |
WO2010119369A3 (en) | A medicinal cream made using silver sulphadiazine and chitosan and a process to make it | |
WO2010109425A3 (en) | A medicinal steroids cream and a process to make it | |
WO2009063493A3 (en) | Topical pharmaceutical composition for the combination of fusidic acid and a corticosteroid | |
WO2011156030A3 (en) | High oil-content emollient aerosol foam compositions | |
MA26834A1 (en) | NEW CONTRACEPTIVE MEDICINAL PRODUCT AND ITS PREPARATION METHOD | |
WO2010119366A3 (en) | A medicinal cream made using fluticasone propionate, and chitosan, and a process to make the same | |
HRP20110429T1 (en) | Foamable composition essentially free of pharmaceutically active ingredients for the treatment of human skin | |
MX2011012143A (en) | Compositions suitable for the topical treatment of fungal infections of the skin and nails. | |
MX2019003685A (en) | Pharmaceutical composition for use in the therapeutic treatment of cancer and complications of cancer. | |
WO2008126076A3 (en) | Low-dose mometasone formulations | |
WO2011074015A3 (en) | Composition of pharmaceutical product to treat sexual dysfunction | |
WO2010119367A3 (en) | A medicinal cream made using hydrocortisone acetate and a process to make the same | |
WO2010122490A3 (en) | A medicinal anti diaper rash cream incorporating a biopolymer and a process to make it | |
MX2011012982A (en) | Topical micro-emulsions for the treatment of rheumatic disorders. | |
RU2358748C2 (en) | Local compositions restoring nail structure | |
WO2010042701A3 (en) | Corticosteroid compositions for use in treating diseases of the upper and lower airway passages | |
MX2011009935A (en) | A medicinal cream for diaper rash and a process to make it. | |
WO2012158405A2 (en) | Compositions and methods for the treatment of skin diseases | |
WO2010119384A3 (en) | A medicinal cream made using mometasone furoate, and chitosan, and a process to make the same | |
WO2018094023A3 (en) | Cyclic dipeptides and wound healing | |
WO2010122473A3 (en) | A medicinal antifungal and steroid cream incorporating a biopolymer and a process to make it | |
WO2010122474A3 (en) | A medicinal antifungal and steroid cream incorporating a biopolymer and a process to make it | |
WO2010119386A3 (en) | A medicinal cream made using clotrimazole, fluticasone propionate, and chitosan, and a process to make the same |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 10717811 Country of ref document: EP Kind code of ref document: A2 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 10717811 Country of ref document: EP Kind code of ref document: A2 |